(Q41121917)

27 September 2017

1 reference

title

Vasoactive hormones and renal sclerosis (English)

1 reference

27 September 2017

Egido J

1

1 reference

PubMed ID

8821847

27 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

27 September 2017

1 reference

27 September 2017

49

1 reference

27 September 2017

2

1 reference

27 September 2017

578-597

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1996.82

27 September 2017

0 references

cites work

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II local hyperreactivity in the progression of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin actions in the kidney: Renewed insight into the old hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The intrarenal renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelins: multifunctional renal peptides

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin-II Receptor Subtypes and Coupling to Signaling Systems in Cultured Fetal Fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal matrix and adhesion in injury and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II causes mesangial cell hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The emerging concept of vascular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Stimulation of vascular glycosaminoglycan synthesis by subpressor angiotensin II in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

ACE inhibitors in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Inhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum (ATS)-induced mesangiolysis in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Nephrotic Proteinuria Without Hypoalbuminemia: Clinical Characteristics and Response to Angiotensin-Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Reversing glomerular hypertension stabilizes established glomerular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal injury from angiotensin II-mediated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Early interstitial changes in hypertension-induced renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Mechanisms of tubulointerstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The paradox of the renin-angiotensin system in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Identification of functional angiotensin II receptors on rat cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Interstitial fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Regulation of renin-angiotensin system in unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Physiologic and pathophysiologic roles of endothelin in the kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Molecular and cellular biology of endothelin and its receptors--Part I.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal actions of endothelin: linking cellular signaling pathways to kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Functional endothelin 1 receptors on human glomerular podocytes and mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelins, peptides with potent vasoactive properties, are produced by human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelin (ET)-3 stimulates cyclic guanosine 3',5'-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Expression of soluble and insoluble fibronectin in rat aorta: effects of angiotensin II and endothelin-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Inhibition by L-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelins. Vascular actions and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Biological actions and pathophysiologic significance of endothelin in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal actions of endothelin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Transcriptional regulation of the endothelin-1 gene by TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of a specific endothelin A receptor antagonist on murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelin-1 mRNA expression by peripheral blood monocytes in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Urinary excretion of endothelin-1 in normal subjects and patients with renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Urinary endothelin: a possible biological marker of renal damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelin: a new inhibitor of renin release

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Inhibition by angiotensin converting enzyme inhibitors of endothelin secretion from cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II causes formation of platelet activating factor in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

RENAL ARTERIOGRAPHY, SEPARATE RENAL-FUNCTION STUDIES AND RENAL BIOPSY IN HUMAN HYPERTENSION. SELECTION OF PATIENTS FOR SURGICAL TREATMENT

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Prevalence of Renovascular Hypertension in Patients with Grade III or IV Hypertensive Retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Continuous versus intermittent angiotensin converting enzyme inhibition in renal hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Prostaglandins and Bartter's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Cytokine stimulated endothelin release from endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Renin expression in renal ablation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Role of reactive oxygen metabolites in experimental glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Differences in the effects of angiotensin converting enzyme inhibitors with or without a thiol group in chronic renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Aldosterone biosynthesis and action in vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Nitric oxide in the kidney: synthesis, localization, and function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Long-term results of steroid therapy in adults with idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effect of captopril on the renal veno-arterial gradient of erythropoietin and oxygen in unilateral renal artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effects of endothelins on collagen turnover in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

TGF-beta: regulation of extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Effects of dietary protein and uninephrectomy on renal angiotensin converting enzyme activity in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.82

7 January 2021

Identifiers

DOI

10.1038/KI.1996.82

1 reference

27 September 2017

1 reference

PubMed ID

8821847